Delivery Order SPE2DB22D3301-SPE2DB24FY2TX
- Not listed
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $8,865.43 award is for the provision of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. This delivery order falls under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $15,602.77 award is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to be completed by February 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The $4,826.06 award is for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The delivery order is set to be completed by February 13, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET UU 30S. The award, valued at $74,288.73, has a completion date of June 23, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December...
- The Defense Logistics Agency (DLA) has awarded a $10,445.23 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VEMLIDY 25 MG TABLET UU 30S. This delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The firm fixed price contract is for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, with a potential value of $2,596.53 and a completion date of February 28, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp holds an Indefinite...
- This is a $1,019.90 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The order is for 4565285836 - VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, with a period of performance ending on July 30, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies to supply a wide range of medical commodities,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,874.67 firm-fixed-price contract is for the supply of VEMLIDY 25 MG TABLET UU 30S, a medical product, with a period of performance through April 2, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET. The $18,983.86 firm fixed price contract has an ultimate completion date of August 23, 2024. Amerisourcebergen, through its Corporate Office Division, is a prominent provider of pharmaceutical and medical products to various government agencies, including the military and federal healthcare...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $3,643.75 Firm Fixed Price delivery order is for the supply of VEMLIDY 25 MG TABLET in a 30-count package. The contract has an ultimate completion date of May 9, 2025. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY2TXDelivery Order
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $19,615.61 award is for the supply of VEMLIDY 25 MG TABLET UU 30S, a prescription pharmaceutical product, with a completion date of March 19, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical and medical supplies to U.S. government agencies, primarily the Department of Defense. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC enables Amerisourcebergen to deliver pharmaceuticals and medical materials to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.6k | 3/18/24 |